Talismanian Devil
Customer interaction management solutions provider Talisma, continuing what its business plan unabashedly calls “aggressive global expansion,” has announced a joint partnership with Japanese reseller Vital to sell Talisma’s newly released Japanese products Talisma CIM 7.0j and CRM 7.0j. The partnership will allow Vital sales reps to peddle Talisma’s solutions in Japan to existing clientele such as Canon, Epson, Sony, Sharp and Toyota.
The Talisma CIM 7.0j product suite includes Talisma email, Talisma Chat, and Talisma Phone and leverages the Talisma Knowledge base. Talisma CRM 7.0j is vertically focused to specialize in the higher education market. The holistic solution seeks to provide increased functionality across the institution and the student / constituent lifecycle.
The Talisma CRM solution was most notably recently deployed at Japan’s prestigious Keio University to enhance fundraising initiatives in association with the institution’s sesquicentennial anniversary celebration in 2008. In addition to releasing the new solutions, Talisma representatives also announced the launch of the company’s first website localised in Japanese at a press conference with Vital at IBM Japan affiliate, LBS. Founded in 1996, Vital Information Inc. has offices in Tokyo and Osaka; U.S. subsidiary Vital USA is headquartered in Redmond, Washington, and has an office in Boston, Mass.
Vital Information combines technological staff from its IT engineer outsourcing business and IT technologies in other countries. Talisma is a customer interaction management solutions provider integrating email, phone, chat, and self service with a web services platform, comprehensive analytics, and a system-wide knowledge base. Among Talisma clintele are AOL, Aviva, Banque Populaire, Betdaq, Canon, ChevronTexaco, Citibank, Dacorum Borough Council, Daimler-Chrysler, Dell, DHL, E.on, EPSON, Ericsson, Intuit, Microsoft, MWB, Pitney Bowes, Siemens, Sony, Sprint, NHS University Hospital of Leicester and Xchanging.
Comments (0)
Trackback URL | Comments RSS Feed